Inventor
HORNBACK WILLIAM J
US17 patents
⚠️ This page may combine multiple inventors who share the name “HORNBACK WILLIAM J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LILLY CO ELI
11 patentsUS5480887AJan 2, 1996
Protease inhibitors
LILLY CO ELI63 citations95
US6127422AOct 3, 2000
Anti-viral method
LILLY CO ELI24 citations88
US6103922AAug 15, 2000
Anti-viral compounds
LILLY CO ELI2 citations62
US5734057AMar 31, 1998
HIV protease inhibitors and intermediates
LILLY CO ELI2 citations62
US5624934AApr 29, 1997
Protease inhibitors
LILLY CO ELI2 citations62
US5578608ANov 26, 1996
Symmetrical diaryl and diheteroanyl cis epoxy alkanes antiviral compounds
LILLY CO ELI2 citations62
US5272265ADec 21, 1993
3-(substituted or unsubstituted) thiazolo-1-carba (1-dethia)cephems
LILLY CO ELI2 citations62
US5179088AJan 12, 1993
1-carba(dethia)cephalosporin antibiotics
LILLY CO ELI2 citations62
US6096917AAug 1, 2000
Anti-viral compounds
LILLY CO ELI3 citations61
US5099015AMar 24, 1992
Trifluoromethyl 1-carba(1-dethia)cephems
LILLY CO ELI4 citations59
US6156924ADec 5, 2000
Anti-viral compounds
LILLY CO ELI1 citations51
AGOURON PHARMA
6 patentsUS5827891AOct 27, 1998
HIV protease inhibtors
AGOURON PHARMA36 citations96
US5952343ASep 14, 1999
HIV protease inhibitors
AGOURON PHARMA8 citations82
US6693199B2Feb 17, 2004
Method of making HIV protease inhibitors
AGOURON PHARMA2 citations73
US6525215B2Feb 25, 2003
HIV protease inhibitors
AGOURON PHARMA2 citations73
US6162812ADec 19, 2000
Pharmaceutical compositions containing HIV protease inhibitors and methods of their use
AGOURON PHARMA2 citations73
US5837710ANov 17, 1998
HIV protease inhibitors
AGOURON PHARMA4 citations73